References

Cornell, M., M. Schomaker, D.B. Garone, J. Giddy and C.J. Hoffmann et al., 2012. Gender differences in survival among adult patients starting antiretroviral therapy in south Africa: A multicentre cohort study. PLoS Med., Vol. 9. 10.1371/journal.pmed.1001304

Deuffic-Burban, S., E. Losina, B. Wang, D. Gabillard and E. Messou et al., 2007. Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Cote d'Ivoire: Impact of alternative methods of CD₄ count modelling. Eur. J. Epidemiol., 22: 737-744.
CrossRef  |  

Eluwa, G.I., T. Badru and K.J. Akpoigbe, 2012. Adverse drug reactions to antiretroviral therapy (ARVs): Incidence, type and risk factors in Nigeria. BMC Pharmacol. Toxicol., Vol. 12. 10.1186/1472-6904-12-7

Jerene, D., A. Endale, Y. Hailu and B. Lindtjorn, 2006. Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect. Dis., Vol. 6. 10.1186/1471-2334-6-136

LDHS, 2009. Ministry of health and social welfare. The United Republic of Tanzania, Bureau of Statistics, Lesotho.

MHSW, 2010. Annual joint review report 2009/10 FY. Ministry of Health and Social Welfare, Lesotho.

MHSW, 2010. National Guidelines for HIV and AIDS Care and Treatment. 3rd Edn., Ministry of Health and Social Welfare, Lesotho.

Mehta, U., D.N. Durrheim, M. Blockman, T. Kredo, R. Gounden and K.I. Barnes, 2008. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: Prospective observational study. Br. J. Clin. Pharmacol., 65: 396-406.
CrossRef  |  

Mocroft, A., B. Ledergerber, C. Katlama, O. Kirk and P.D. Reiss et al., 2003. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362: 22-29.
CrossRef  |  Direct Link  |  

Muula, A.S., T.J. Ngulube, S. Siziya, C.M. Makupe and E. Umar et al., 2007. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: A systematic review. BMC Publ Health, Vol. 7. 10.1186/1471-2458-7-63

Nunez, M.J., L. Martin-Carbonero, V. Moreno, E. Valencia and J. Garcia-Samaniego et al., 2006. Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients. AIDS Res. Human Retroviruses, 22: 825-829.
CrossRef  |  Direct Link  |  

Ogoina, D., R.O. Obiako, H.M. Muktar, M. Adeiza and A. Babadoko et al., 2012. Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: A 4-year retrospective review from Zaria, Northern Nigeria. AIDS Res. Treatment, 10.1155/2012/940580

Ojikutu, B., 2007. The realities of antiretroviral therapy rollout: Overcoming challenges to successful programmatic implementation. J. Infect. Dis., 196: S445-S448.
CrossRef  |  Direct Link  |  

Palella, Jr. F.J., K.M. Delaney, A.C. Moorman, M.O. Loveless and J. Fuhrer et al., 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med., 338: 853-860.
CrossRef  |  Direct Link  |  

Skovdal, M., C. Campbell, C. Madanhire, Z. Mupambireyi, C. Nyamukapa and S. Gregson, 2011. Masculinity as a barrier to men's use of HIV services in Zimbabwe. Globalization Health, Vol. 7.

Subbaraman, R., S.K. Chaguturu, K.H. Mayer, T.P. Flanigan and N. Kumarasamy, 2007. Adverse effects of highly active antiretroviral therapy in developing countries. Clin. Infect. Dis., 45: 1093-1101.
CrossRef  |  Direct Link  |  

Szczech, L.A., 2008. Renal dysfunction and tenofovir toxicity in HIV-infected patients. Top. HIV Med., 16: 122-126.
Direct Link  |  

Vives, N., D. Carnicer-Pont, P. Garcia de Olalla, N. Camps, A. Esteve, J. Casabona and HIV and STI Surveillance Group, 2012. Factors associated with late presentation of HIV infection in Catalonia, Spain. Int. J. STD AIDS, 23: 475-480.
PubMed  |